Patents
Patents for C12N 1 - Micro-organisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving micro-organisms or compositions thereof; Processes of preparing or isolating a composition containing a micro-organism; Culture media therefor (148,866)
11/2003
11/13/2003WO2003093470A1 Gene relating to saccharide metabolism or lipid metabolism
11/13/2003WO2003093465A1 FACTOR VII OR VIIa POLYPEPTIDE VARIANTS
11/13/2003WO2003093461A2 Genomic library of cyanophage s-2l and functional analysis
11/13/2003WO2003093454A1 A microbe preparation for treating waste alcohol, its preparation method and the fermentation process
11/13/2003WO2003093453A2 Bacillus licheniformis mutant host cell
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093432A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003WO2003093424A2 In vivo ssdna expression vectors for altering gene expression
11/13/2003WO2003093411A2 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/13/2003WO2003093406A2 Microfermentors for rapid screening and analysis of biochemical processes
11/13/2003WO2003093317A1 Antibody to human insulin-like growth factor
11/13/2003WO2003093200A2 Method for synthesis of aryl-carotenoids
11/13/2003WO2003092737A1 Fusions of cytokines and tumor targeting proteins
11/13/2003WO2003092628A2 High-quality lipids and methods for producing by enzymatic liberation from biomass
11/13/2003WO2003092600A2 Site specific listeria integration vectors and methods for using the same
11/13/2003WO2003092587A2 Modulation of bacterial membrane permeability
11/13/2003WO2003072739A3 Trans-splicing mediated imaging of gene expression
11/13/2003WO2003068955A3 Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins
11/13/2003WO2003061365A3 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003047526A3 Cell adhesion and extracellular matrix proteins
11/13/2003WO2003040391A3 Method for producing and identifying soluble protein domains
11/13/2003WO2003040372A3 Polynucleotides and polypeptides involved in clavulinic acid biosynthesis and use thereof
11/13/2003WO2003040291A3 Genes encoding for carbon metabolism and energy-producing proteins
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003031621A3 A human g protein coupled receptor
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003028536A3 Methods for diagnosing and treating heart disease
11/13/2003WO2003018826A3 Method for producing vitamin b12
11/13/2003WO2003018813A3 Ashbya gossypii enzymes
11/13/2003WO2003012111A3 Conjugates for the modulation of immune responses
11/13/2003WO2003008607A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/13/2003WO2003008600A3 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family
11/13/2003WO2003008534A3 Polypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
11/13/2003WO2003000918A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
11/13/2003WO2002102984A3 Hdac9 polypeptides and polynucleotides and uses thereof
11/13/2003WO2002099115A3 Nucleic acid-associated proteins
11/13/2003WO2002095058A9 Emission ratiometric indicators of phosphorylation
11/13/2003WO2002095056A3 A novel g protein-coupled receptor, gave1
11/13/2003WO2002095002A3 N4 virion single-stranded dna dependent rna polymerase
11/13/2003WO2002094867A3 Sequence of the photorhabdus luminescens strain tt01 genome and uses
11/13/2003WO2002092831A3 Method for identifying ligands for g protein coupled receptors
11/13/2003WO2002088371A3 Method for the production of an aqueous acrylamide solution with a bio-catalyst
11/13/2003WO2002065836A3 Delivery systems for mycotechnologies, mycofiltration and mycoremediation
11/13/2003WO2002057302A8 A virus causing respiratory tract illness in susceptible mammals
11/13/2003WO2002056893A8 Novel receptors for $i(helicobacter pylori) and use thereof
11/13/2003WO2002034909A3 Engineered chimera of hiv protein fragments and uses thereof
11/13/2003WO2002026041A9 A novel strain of streptomyces for controlling plant diseases
11/13/2003WO2002014551A9 Bioluminescent methods for direct visual detection of environmental compounds
11/13/2003WO2002014348B1 Glycoproteins and methods of use thereof
11/13/2003WO2000021978A3 Laminin 5, 13 and 14 and uses thereof
11/13/2003US20030213012 Pesticidal agents
11/13/2003US20030212266 Growth arrest homeobox gene
11/13/2003US20030212265 Detection using genetic engineered nucleic acid
11/13/2003US20030212262 Human serine racemase
11/13/2003US20030212259 Recombinant photoproteins and their conjugates
11/13/2003US20030212252 Comprises g-protein coupled receptor polypeptide, melanin-concentrating hormone receptor (MCH) for treating hypertension, diabetes, cancer, dyslipidemias, cardiovascular disease, gall stones and osteoarthritis
11/13/2003US20030211996 Virus like particles
11/13/2003US20030211990 Central nervous system disorders; test kits
11/13/2003US20030211984 Genetic engineering; antibodies; libraries
11/13/2003US20030211958 Alpha-amylase mutants
11/13/2003US20030211615 System for detection of a functional interaction between a compound and a cellular signal transduction component
11/13/2003US20030211599 Miniature achromosomal and anucleate cell for use as drug delivery system; antitumor/antiproliferative agents
11/13/2003US20030211594 Microalgae for remediation of waste and method of culturing the same
11/13/2003US20030211593 Comprises polymerase with modified exonuclease activity for use as amplification tool in DNA replication reactions
11/13/2003US20030211577 Novel G protein-coupled receptor, GAVE7
11/13/2003US20030211573 Preparing glycoprotein in cells using enhanced carbamoyl-phosphate synthase II (CPS II)/aspartate transcarbamoylase (ATCase)/dihydro-orotase (CAD) enzyme; drug delivery and design
11/13/2003US20030211570 Comprises nucleotide sequences coding membrane protein for use in treatment of tumors and cell proliferative diseases; antiinflammatory agents
11/13/2003US20030211567 Compositions, methods and systems for discovery of lipopeptides
11/13/2003US20030211563 Human testis specific serine/threonine kinase 1 & 2
11/13/2003US20030211552 Cyclic GMP dependent protien kinase as a chemotherapeutic target for antiprotozoal agents
11/13/2003US20030211541 Using immunological means to identify growth differentiation factor-14 (GDF-14) for treating cell proliferative and immunological disorders; gene expression inhibition; antiproliferative agents
11/13/2003US20030211540 Treatment of insulin resistance
11/13/2003US20030211529 Human Eag2
11/13/2003US20030211515 Comprises nucleotide sequences coding matrix protein for diagnosing and treating cancer
11/13/2003US20030211514 Comprises nucleotide sequences coding polypeptide for use in diagnosis and treatment of neoplastic and neurodegenerative diseases
11/13/2003US20030211513 Intracellular signaling proteins
11/13/2003US20030211506 Comprises nucleotide sequences coding Bacillus endonuclease and modification methylase for propagating nucleotide sequences using strand displacement amplification
11/13/2003US20030211493 Comprises membrane protein for diagnosis, prevention and treatment of infections, cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory and metabolic disorders
11/13/2003US20030211467 Using monoclonal antibody for diagnosis, prevention and treatment of viral infections; immunotherapy; genetic vaccine
11/13/2003US20030211457 Methods and kits for testing mutagenicity
11/13/2003US20030211453 Nucleotide sequences coding fertility associated antigen (FAA) for diagnosis and treatment of sexual or urogenital disorders
11/13/2003US20030211118 Immunizing compositions and methods of use
11/13/2003US20030211106 Binding tumor necrosis factor to antibody
11/13/2003US20030211101 Vascular endothelial growth factor-like protein from ORF viruses binds and activates mammalian VEGF receptor-2, and uses thereof
11/13/2003US20030211100 Gene therapy; nucleic acid coding immunoglobulins; anticancer agents
11/13/2003US20030211089 Transgenic algae for delivering antigens to an animal
11/13/2003CA2485089A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
11/13/2003CA2484425A1 Fusions of cytokines and tumor targeting proteins
11/13/2003CA2484334A1 High-quality lipids and methods for producing by enzymatic liberation from biomass
11/13/2003CA2484185A1 Site specific listeria integration vectors and methods for using the same
11/13/2003CA2483912A1 Alcam and alcam modulators
11/13/2003CA2483706A1 Genomic library of cyanophage s-2l and functional analysis
11/13/2003CA2483478A1 Factor vii or viia polypeptide variants
11/13/2003CA2483050A1 Optimization of transgene expression in mammalian cells
11/13/2003CA2483047A1 Ice1, a regulator of cold induced transcriptome and freezing tolerance in plants
11/12/2003EP1361278A2 Process for the production of amino acids using phosphoglucose isomerases from coryneform bacteria
11/12/2003EP1361277A1 Optimization of transgene expression in mammalian cells
11/12/2003EP1361276A1 Pro-urokinase mutants